NWBO

Northwest Biotherapeutics, Inc. News Headlines

$5.45
*  
0.22
3.88%
Get NWBO Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading NWBO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Agenus: Some More Thoughts On The Potential For Prophage
9/22/2013 7:27:00 PM - Seeking Alpha

Agenus: Thoughts On Phase II Results For Prophage In Glioblastoma
9/18/2013 2:18:00 PM - Seeking Alpha

Agenus: Thoughts On Phase II Results For Prophage In Glioblastoma
9/18/2013 2:17:13 PM - SeekingAlpha

Agenus: Assessing Stock Prospects After MAGE A-3 Cancer Vaccine Misses Primary Endpoint In Melanoma
9/5/2013 2:45:00 PM - Seeking Alpha

A Public Apology To Adam Feuerstein On Northwest Biotherapeutics
8/29/2013 5:51:00 PM - Seeking Alpha

A Closer Scientific Look At Northwest Biotherapeutics' Lead Candidate
8/29/2013 4:45:00 PM - Seeking Alpha

Agenus: Upcoming MAGE A-3 Clinical Trial Results Will Have A Major Impact On The Stock
8/21/2013 1:30:00 PM - Seeking Alpha

Agenus: Upcoming MAGE A-3 Clinical Trial Results Will Have A Major Impact On The Stock
8/21/2013 1:21:49 PM - SeekingAlpha

Northwest Biotherapeutics Is Trying To Pull An Onyx With DCVax-Direct
8/9/2013 4:00:00 PM - Seeking Alpha

A Small Biotech With Breakthrough Potential In Cancer Treatment
7/22/2013 10:55:00 AM - Seeking Alpha

Agenus: Key Clinical Events Are Imminent
7/17/2013 11:14:08 PM - SeekingAlpha

Agenus: Key Clinical Events Are Imminent
7/17/2013 11:14:08 PM - SeekingAlpha

Membership Has Its Privileges: The Upside Of Joining The Indexes
6/29/2013 4:38:00 AM - Seeking Alpha

Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
6/17/2013 9:00:00 AM - Minyanville

Northwest Bio: M.D. Anderson's Lead Role In DC Vax Direct Trial Is Encouraging
6/13/2013 8:59:00 AM - Seeking Alpha

SmithOnStocks Opines Week Of June 2, 2013
6/3/2013 7:00:00 AM - Seeking Alpha

DelMar Pharmaceuticals To Present Updated Phase I GBM Data At ASCO
5/30/2013 11:48:00 AM - Seeking Alpha

SmithOnStocks Opines On Biotechnology Stocks, May 24, 2013
5/27/2013 10:09:00 AM - Seeking Alpha

SmithOnStocks Opines On Recent Biotech News
5/13/2013 5:38:00 AM - Seeking Alpha

Northwest Biotherapeutics: Moving DC Vax-L Rapidly Forward And Starting DC Vax Direct Trials
5/7/2013 8:23:00 PM - Seeking Alpha

With A New Institutional Investor On Board, Northwest Biotherapeutics Breaks The Curse
5/1/2013 10:37:00 AM - Seeking Alpha

Northwest Biotherapeutics, Statistically Speaking
4/11/2013 5:24:00 PM - Seeking Alpha

Biotechs With Staggering Potential: Grant Zeng
4/5/2013 10:19:00 AM - Seeking Alpha

Survival Strategies For Development Biotechs And How They Affect Share Prices
3/28/2013 10:42:00 AM - Seeking Alpha

ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107
3/27/2013 10:32:05 AM - SeekingAlpha